Anoro Ellipta FDA Approval History
FDA Approved: Yes (First approved December 18, 2013)
Brand name: Anoro Ellipta
Generic name: umeclidinium bromide and vilanterol
Treatment for: COPD
Anoro Ellipta (umeclidinium bromide and vilanterol) is a long-acting muscarinic antagonist (LAMA) and long-acting beta2 agonist (LABA) combination for the treatment of COPD.
Development timeline for Anoro Ellipta
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.